Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 10365148)

Published in Anticancer Res on June 29, 1999

Authors

W Schafhauser1, A Ebert, J Brod, S Petsch, K M Schrott

Author Affiliations

1: Department of Urology, University of Erlangen-Nürnberg, Germany. schafhauser@uro.med.uni-erlangen.de

Articles by these authors

(truncated to the top 100)

The rational basis of diagnosis in internal medicine. J R Coll Physicians Lond (1977) 2.58

Gene cluster for streptomycin biosynthesis in Streptomyces griseus: nucleotide sequence of three genes and analysis of transcriptional activity. Nucleic Acids Res (1987) 2.28

Hydrogen Concentration Profiles at the Oxic-Anoxic Interface: a Microsensor Study of the Hindgut of the Wood-Feeding Lower Termite Reticulitermes flavipes (Kollar). Appl Environ Microbiol (1997) 1.50

Pathogenesis of cardiac oedema. Br Med J (1972) 1.44

Twelve testable hypotheses on the geobiology of weathering. Geobiology (2011) 1.42

[Long-term experience with percutaneous endoscopic controlled gastrostomy (PEG) in ENT tumor patients]. HNO (1998) 1.40

Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer. Strahlenther Onkol (1998) 1.38

Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther (2006) 1.38

AIDS counselling for low-risk clients. AIDS Care (1998) 1.28

Conversion of androstenedione to estrone by human tissue. J Clin Endocrinol Metab (1972) 1.18

Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys (1990) 1.17

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys (1998) 1.16

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension. Br J Clin Pharmacol (1979) 1.10

Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging (2013) 1.08

Heterogeneous expression of glutamine synthetase mRNA in rat liver parenchyma revealed by in situ hybridization and Northern blot analysis of RNA from periportal and perivenous hepatocytes. FEBS Lett (1988) 1.07

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys (2000) 1.07

What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol (1991) 1.06

[Organ-preserving therapy in invasive bladder carcinoma]. Dtsch Med Wochenschr (1992) 1.06

Improving social perception in schizophrenia: the role of oxytocin. Schizophr Res (2013) 1.06

Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord (2010) 1.04

Gene cluster for streptomycin biosynthesis in Streptomyces griseus: analysis of a central region including the major resistance gene. Mol Gen Genet (1987) 1.02

Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. Clin Cancer Res (1996) 1.00

Effect of diazoxide on capacitance vessels. Eur J Clin Pharmacol (1978) 1.00

Haemodynamics of hypertension in chronic renal disease. Contrib Nephrol (1977) 0.99

[Iohexol in excretory urography. Results of drug monitoring]. Fortschr Med (1986) 0.97

[The capacity system in hypertension]. Verh Dtsch Ges Inn Med (1974) 0.96

Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys (1994) 0.94

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. Eur Urol (2001) 0.93

Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity. Eur J Clin Pharmacol (1972) 0.92

In vitro study concerning the efficiency of the frequency-doubled double-pulse Neodymium:YAG laser (FREDDY) for lithotripsy of calculi in the urinary tract. Lasers Surg Med (1999) 0.91

[Continent reconstruction of an extreme urogenital sinus--case report of a so-called high vesicovaginal confluence]. Urologe A (1988) 0.90

[Cryotherapy of bladder cancer]. Urologe (1968) 0.89

Comparison of haemodynamic effects of equipressor doses of intravenous angiotensin and noradrenaline in man. Clin Sci (1969) 0.89

Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons. Dev Neurosci (2006) 0.88

[Retroperitoneal ganglioneuroma]. Aktuelle Urol (2005) 0.87

Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J Urol (1990) 0.87

Invasive bladder cancer: organ preservation by radiochemotherapy. Front Radiat Ther Oncol (2002) 0.86

Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy. Gynecol Oncol (1996) 0.85

Comparison of preoperative innervation pattern and postreconstructive urodynamics in the exstrophy-epispadias complex. Urol Int (1997) 0.84

What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients? Cerebrovasc Dis (2013) 0.84

[The significance of tumor diameter in renal cell carcinoma]. Urologe A (1992) 0.84

Mechanisms for the elevation of blood pressure in human renal disease. Preliminary report. Hypertension (1983) 0.83

Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol (2001) 0.83

Identification of Cripto-1 in human milk. Breast Cancer Res Treat (2001) 0.82

Development of hypertension in renal disease. Clin Sci (Lond) (1983) 0.81

Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group. Med Oncol Tumor Pharmacother (1989) 0.81

Haemodynamic response to an acute emotional stress (mental arithmetic) with special reference to the venous side. Aust N Z J Med (1976) 0.81

Investigations on the Na+, K+-pump in erythrocytes of patients with renal hypertension. Clin Sci (Lond) (1984) 0.81

[Relationship between sound size, freezing speed and cell death in cryotherapy]. Urologe (1970) 0.80

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial. Eur J Cancer (2004) 0.80

The measurement of the renal venous outflow in man by the local thermodilution method. Nephron (1971) 0.80

Does the distance to normal renal parenchyma (DTNRP) in nephron-sparing surgery for renal cell carcinoma have an effect on survival? Anticancer Res (2005) 0.80

Chick CFC controls Lefty1 expression in the embryonic midline and nodal expression in the lateral plate. Dev Biol (2001) 0.80

[The reaction of the healthy urinary bladder to extreme cold lesion. Experimental studies with liquid nitrogen]. Urologe (1968) 0.80

Study of renal function in the differential diagnosis of kidney disease. Br Med J (1971) 0.79

Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines. Anticancer Res (2007) 0.79

PROGINS polymorphism of progesterone receptor is increased in female offspring with maternal exposure to diethylstilbestrol. Anticancer Res (2001) 0.79

[Effect of emotional stress (mental arithmetics) on venous circulation]. Vnitr Lek (1970) 0.79

Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells. Cell Death Differ (2000) 0.78

Central and peripheral circulation after an isotonic volume expansion with saline in human subjects. Contrib Nephrol (1980) 0.78

Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice. Horm Metab Res (2002) 0.78

[Diabetic retinopathy and nephropathy--complications in pregnancy and labor]. Geburtshilfe Frauenheilkd (1995) 0.78

[Endometriosis of the ureter and urinary bladder]. Urologe A (2007) 0.78

Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma? J Urol (2002) 0.78

Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Strahlenther Onkol (2001) 0.78

[Changes in therapy for breast cancer patients as a result of mammography screening. An analysis of Bavarian cancer registry data from 2000 to 2008]. Gesundheitswesen (2013) 0.78

[Congenital megaureter and its implications]. Urologe A (1982) 0.78

Forearm vessels in hypertension of chronic renal disease. Contrib Nephrol (1982) 0.78

Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease. Nephron (1980) 0.78

[The clinical importance of keratin 18 in breast cancer]. Zentralbl Gynakol (1999) 0.77

Effects of aging on the glomerular capillaries, blood pressure, and renal function in rats. Contrib Nephrol (1982) 0.77

A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline. J Neurol Sci (2010) 0.77

Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma. Anticancer Res (1999) 0.77

Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin. Int J Radiat Oncol Biol Phys (1988) 0.76

[Ventral urethral diverticulum. Case report of a 10-year-old girl]. Urologe A (1999) 0.76

Current use of HER2 tests. Ann Oncol (2001) 0.75

Green College lectures: 1984. Medicine in eastern Europe. Br Med J (Clin Res Ed) (1984) 0.75

Volume homeostasis, renal function and hypertension. Ulster Med J (1985) 0.75

Prostatic acid phosphatase in the serially transplantable human prostatic tumor lines PC-82 and PC-EW. Urol Res (1990) 0.75

Femoral duplication and the developmental field. Am J Med Genet (1990) 0.75

[Medical impressions from a trip to Australia and New Zealand]. Cas Lek Cesk (1968) 0.75

[Water and potassium metabolism changes]. Minerva Med (1976) 0.75

Clinical and haemodynamic study of a new vasodilator drug L6150 (3-[bis-(2-hydroxyethyl)amino]-6-hydrazinopyridazine) in man. Clin Sci Mol Med Suppl (1976) 0.75

Muscle blood flow in heart failure. Kardiol Pol (1968) 0.75

The effect of intravenous angiotensin II on the peripheral circulation with particular reference to its bearing on general haemodynamics. Clin Sci Mol Med Suppl (1976) 0.75

Mechanisms and recent advances in therapy of hypertension. Introduction. From Prague to Hannover. Contrib Nephrol (1977) 0.75

Effects of the vasodilating drugs (Diazoxide and Epidrazine) on the central and peripheral circulation. Contrib Nephrol (1977) 0.75

Effect of correction of anemia on the glomerular filtration rate in chronic renal failure. Isr J Med Sci (1967) 0.75

Hypertension and renal parenchymal disease: mechanisms and management. Cardiovasc Clin (1978) 0.75

[Measurement of renal venous blood flow in man, using the local thermodilution technic]. Cas Lek Cesk (1970) 0.75

Central and peripheral haemodynamic effects of angiotensin. Contrib Nephrol (1977) 0.75

[Differential diagnosis of proteinuria]. Dtsch Med J (1969) 0.75

[Factors affecting long term prognosis of patients with chronic pyelonephritis]. Vnitr Lek (1968) 0.75

[Disturbances of Free Water and Electrolyte Metabolism: Three large groups are differentiated]. MMW Munch Med Wochenschr (1976) 0.75

Nephrologist's thoughts on toxaemia of pregnancy. Panminerva Med (1978) 0.75

Vascular lesions in human allotransplantated kidneys. Virchows Arch A Pathol Pathol Anat (1970) 0.75

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension. Br J Clin Pharmacol (1979) 0.75

Haemodynamics and emotional stress. Bibl Psychiatr (1970) 0.75

[Chronic pyelonephritis]. Rev Med Liege (1969) 0.75

Phenacetin abuse and chronic pyelonephritis. Nephron (1977) 0.75